Casadevall, N. Et Al. 2016. EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS (SC) HX575 EPOETIN ALFA IN THE TREATMENT OF ANAEMIA ASSOCIATED WITH CKD. 53rd ERA-EDTA Congress , (Vienna, Austria), 194.

Casadevall, N., Dobronravov, V., Eckardt, K., ERTÜRK, Ş., Martynyuk, L., Schmitt, S., ... Ode, M.(2016). EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS (SC) HX575 EPOETIN ALFA IN THE TREATMENT OF ANAEMIA ASSOCIATED WITH CKD . 53rd ERA-EDTA Congress (pp.194). Vienna, Austria

Casadevall, Nicole Et Al. "EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS (SC) HX575 EPOETIN ALFA IN THE TREATMENT OF ANAEMIA ASSOCIATED WITH CKD," 53rd ERA-EDTA Congress, Vienna, Austria, 2016

Casadevall, Nicole Et Al. "EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS (SC) HX575 EPOETIN ALFA IN THE TREATMENT OF ANAEMIA ASSOCIATED WITH CKD." 53rd ERA-EDTA Congress , Vienna, Austria, pp.194, 2016

Casadevall, N. Et Al. (2016) . "EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS (SC) HX575 EPOETIN ALFA IN THE TREATMENT OF ANAEMIA ASSOCIATED WITH CKD." 53rd ERA-EDTA Congress , Vienna, Austria, p.194.

@conferencepaper{conferencepaper, author={Nicole Casadevall Et Al. }, title={EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS (SC) HX575 EPOETIN ALFA IN THE TREATMENT OF ANAEMIA ASSOCIATED WITH CKD}, congress name={53rd ERA-EDTA Congress}, city={Vienna}, country={Austria}, year={2016}, pages={194} }